Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Stone, John
Item TypeName
Academic Article Comparison of disease activity measures for anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis.
Academic Article B-cell depleting agents for ANCA vasculitides: a new therapeutic approach.
Academic Article Rituximab versus cyclophosphamide for ANCA-associated vasculitis.
Concept Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Academic Article Circulating markers of vascular injury and angiogenesis in antineutrophil cytoplasmic antibody-associated vasculitis.
Academic Article Circulating angiopoietin-2 as a biomarker in ANCA-associated vasculitis.
Academic Article Serum proteins reflecting inflammation, injury and repair as biomarkers of disease activity in ANCA-associated vasculitis.
Academic Article Efficacy of remission-induction regimens for ANCA-associated vasculitis.
Academic Article Induction regimens for ANCA-Associated Vasculitis.
Academic Article Peripheral CD5+ B cells in antineutrophil cytoplasmic antibody-associated vasculitis.
Academic Article Rituximab for the treatment of relapses in antineutrophil cytoplasmic antibody-associated vasculitis.
Academic Article Rituximab versus cyclophosphamide for ANCA-associated vasculitis with renal involvement.
Academic Article Outcomes of nonsevere relapses in antineutrophil cytoplasmic antibody-associated vasculitis treated with glucocorticoids.
Academic Article Neutrophil-Related Gene Expression and Low-Density Granulocytes Associated With Disease Activity and Response to Treatment in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Academic Article Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type.
Academic Article Using Mass Spectrometry to Quantify Rituximab and Perform Individualized Immunoglobulin Phenotyping in ANCA-Associated Vasculitis.
Academic Article Factors Determining the Clinical Utility of Serial Measurements of Antineutrophil Cytoplasmic Antibodies Targeting Proteinase 3.
Grant Vasculitis Outcome Measures: Development and Validation
Grant Vasculitis Outcome Measures: Development and Validation
Academic Article Effect of Disease Activity, Glucocorticoid Exposure, and Rituximab on Body Composition During Induction Treatment of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Academic Article The Pharmacogenomic Association of Fc? Receptors and Cytochrome P450 Enzymes With Response to Rituximab or Cyclophosphamide Treatment in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Academic Article Identification of Functional and Expression Polymorphisms Associated With Risk for Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis.
Academic Article Association of Serum Calprotectin (S100A8/A9) Level With Disease Relapse in Proteinase 3-Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Academic Article Interstitial Immunostaining and Renal Outcomes in Antineutrophil Cytoplasmic Antibody-Associated Glomerulonephritis.
Academic Article Pharmacokinetics of rituximab and clinical outcomes in patients with anti-neutrophil cytoplasmic antibody associated vasculitis.
Academic Article The Utility of Urinalysis in Determining the Risk of Renal Relapse in ANCA-Associated Vasculitis.
Academic Article Reducing glucocorticoid duration in ANCA-associated vasculitis: A pilot trial.
Academic Article Brief Report: Circulating Cytokine Profiles and Antineutrophil Cytoplasmic Antibody Specificity in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Academic Article Disease Activity, Antineutrophil Cytoplasmic Antibody Type, and Lipid Levels in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Academic Article Association of Pulmonary Hemorrhage, Positive Proteinase 3, and Urinary Red Blood Cell Casts With Venous Thromboembolism in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Academic Article The association of serum interleukin-6 levels with clinical outcomes in antineutrophil cytoplasmic antibody-associated vasculitis.
Academic Article Reply.
Academic Article All-cause and cause-specific mortality in ANCA-associated vasculitis: overall and according to ANCA type.
Academic Article Personalized Medicine in ANCA-Associated Vasculitis ANCA Specificity as the Guide?
Academic Article Association of Cigarette Smoking With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Academic Article Clinical Utility of Serial Measurements of Antineutrophil Cytoplasmic Antibodies Targeting Proteinase 3 in ANCA-Associated Vasculitis.
Academic Article Topic modeling to characterize the natural history of ANCA-Associated vasculitis from clinical notes: A proof of concept study.
Academic Article ANCA-associated Vasculitis Management in the United States: Data From the Rheumatology Informatics System for Effectiveness (RISE) Registry.
Academic Article 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Academic Article 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Academic Article Association of renal transplantation with reduced risk of myocardial infarction and ischemic stroke in ANCA-associated vasculitis: An observational cohort study.
Academic Article Circulating autoreactive proteinase 3+ B cells and tolerance checkpoints in ANCA-associated vasculitis.
Search Criteria
  • Anti Neutrophil Cytoplasmic Antibody Associated Vasculitis
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.